Abstract
Background: Urinary tract infection (UTI) is a prevalent medical complication during pregnancy, affecting approximately 5–10% of all pregnancies. The risk of recurrent bacteriuria and acute pyelonephritis is heightened during pregnancy, posing significant risks to both mother and fetus. The prevalence of bacteriuria varies across different regions globally. Due to the physiological changes during pregnancy, clinical diagnosis of UTI can be challenging as it is often mistaken for regular pregnancy-related changes. This research aims to determine the prevalence of symptomatic UTI in pregnant women, analyze the bacteriological profile and antibiotic resistance, and identify the associated risk factors. Materials and methods: This cross-sectional retrospective study was conducted at the Kasturba Hospital from January 2017 to December 2021. Patient information was obtained from the medical records. Data analysis was carried out using Jamovi 2.3.26. The level of significance was set at 5% throughout the study. Results: The study included a total of 256 pregnant women, out of which 38 patients exhibited notable bacterial growth, resulting in an overall prevalence of 1.94%. Among the pregnant women, 84% presented with symptomatic bacteriuria. Conclusion: UTI during pregnancy has significant implications for the health of both the mother and the baby. Our findings indicate an incidence rate of 1.94% for UTI in pregnant women. Among the isolated organisms, Escherichia coli was the most commonly identified, with a higher prevalence rate observed in the third trimester of pregnancy. Pregnant women who develop UTI are at an elevated risk of experiencing adverse maternal and fetal outcomes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call